zinc protoporphyrin ix has been researched along with Temporomandibular Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abreu, SC; Alves, SM; Bezerra, MM; Chaves, HV; Cristino-Filho, G; de Castro Brito, GA; de Paulo Teixeira Pinto, V; do Val, DR; Freitas, RS; Gomes, FIF; Lemos, JC; Pereira, KMA | 1 |
| Arriaga, AM; Arriaga, NC; Benevides, NM; Bezerra, MM; Brito, GA; Chaves, HV; Cristino-Filho, G; do Val, DR; Lemos, JC; Pereira, KM; Pinto, VP; Rios, LC; Santiago, GM; Silva, AA; Silva, FR; Vasconcelos, JN | 1 |
2 other study(ies) available for zinc protoporphyrin ix and Temporomandibular Disorders
| Article | Year |
|---|---|
Anti-inflammatory and anti-nociceptive effects of strontium ranelate on the zymosan-induced temporomandibular joint inflammatory hypernociception in rats depend on TNF-α inhibition.
Topics: Animals; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Inflammation; Interleukin-1beta; Male; Pain; Protoporphyrins; Rats; Rats, Wistar; Temporomandibular Joint Disorders; Thiophenes; Tumor Necrosis Factor-alpha; Zymosan | 2017 |
Tephrosia toxicaria Pers. reduces temporomandibular joint inflammatory hypernociception: the involvement of the HO-1 pathway.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Heme Oxygenase-1; Hyperalgesia; Inflammation; Male; Metabolic Networks and Pathways; Mice; Phytotherapy; Plant Preparations; Protoporphyrins; Rats; Rats, Wistar; Temporomandibular Joint Disorders; Tephrosia; Zymosan | 2014 |